Purpose of the company: Provision of a customer service platform for marketing, sales, and distribution of analytical and preparatory life sciences systems, such as (but not limited to) Fluidigm's BioMark and BioMark HD systems, Access Array System, C1 Single-Cell Auto Prep System, Juno System, CyTOF and CyTOF 2 systems, and related consumables in Germany.
Adress: Zielstattstr. 40 81379 MĂŒnchen Deutschland
Local court: 80333 MĂŒnchen
Register number: HRB210542
The average total assets of company Standard BioTools GmbH over the last 4 years is 2.493.063,95 âŹ.
The company Standard BioTools GmbH as of the reporting date 2022 a bank balance of approx. 778.540,27 âŹ. That is 4,11 % more than the average bank balance in the industry of companies with this total assets.
The equity ratio of Standard BioTools GmbH is 6,81 % in the year 2022. In total, that ist 164.688,87 âŹ.
The average absolute change in liquidity of the company Standard BioTools GmbH compared to the previous year amounts to 62.984,83 âŹ. That means that the liquidity of the company has increased or decreased by this amount per year on average.
The cash flow of the company Standard BioTools GmbH amounts to 188.954,48 ⏠in the year 2022.
The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.
The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).
All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.
Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.